Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan.
Section of Pediatric Surgery, Department of Surgery, University of Michigan, C.S. Mott Children's Hospital, Ann Arbor, Michigan; Department of Surgery, Maine Medical Center, Portland, Maine.
J Surg Res. 2024 Jun;298:371-378. doi: 10.1016/j.jss.2024.03.039. Epub 2024 Apr 25.
While Enhanced Recovery After Surgery (ERAS) protocols are becoming more common in pediatric surgery, there is still little published about protocol compliance and sustainability.
This is a prospective observational study to evaluate the compliance of an ERAS protocol for pectus repair at a large academic children's hospital. Our primary outcome was overall protocol compliance at 1-y postimplementation of the ERAS protocol. Our comparison group included all pectus repairs for 2 y before protocol implementation.
Overall protocol compliance at 12 mo was 89%. Of the 16 pectus repairs included in the ERAS protocol group, 94% (n = 15) and 94% (n = 15) received preoperative acetaminophen and gabapentin, respectively, which was significantly greater than the historical control group (P < 0.001). For the intraoperative components analyzed, only the intrathecal morphine was significantly different than historical controls (100% versus 49%, P < 0.001). Postoperatively, the time from operating room to return to normal diet was shorter for the ERAS group (0.53 d versus 1.16 d, P < 0.001). There was no significant difference in readmission rates between the two groups.
ERAS protocol compliance varies based on phase of care. Solutions to sustain protocols depend on the institution and the patient population. However, the utilization of implementation science fundamentals was invaluable in this study to identify and address areas for improvement in protocol compliance. Other institutions may adapt these strategies to improve protocol compliance at their centers.
尽管术后强化康复(ERAS)方案在小儿外科中越来越常见,但关于方案的依从性和可持续性仍知之甚少。
这是一项前瞻性观察研究,旨在评估大型学术儿童医院的胸廓成形术 ERAS 方案的依从性。我们的主要结局是 ERAS 方案实施后 1 年的整体方案依从性。我们的对照组包括方案实施前 2 年的所有胸廓成形术。
12 个月时的整体方案依从率为 89%。在 ERAS 方案组的 16 例胸廓成形术中,分别有 94%(n=15)和 94%(n=15)接受了术前对乙酰氨基酚和加巴喷丁,明显高于历史对照组(P<0.001)。对于分析的术中部分,只有鞘内吗啡与历史对照组有显著差异(100%比 49%,P<0.001)。术后,ERAS 组从手术室到恢复正常饮食的时间更短(0.53d 比 1.16d,P<0.001)。两组的再入院率无显著差异。
ERAS 方案的依从性取决于护理阶段。维持方案的解决方案取决于机构和患者人群。然而,在这项研究中,实施科学基础的利用对于确定和解决方案依从性方面的改进领域是非常宝贵的。其他机构可以采用这些策略来提高其中心的方案依从性。